New Pre-pandemic Influenza Vaccines: An Egg- and Adjuvant-independent Human Adenoviral Vector Strategy Induces Long-lasting Protective Immune Responses in Mice
- 24 October 2007
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 82 (6) , 665-671
- https://doi.org/10.1038/sj.clpt.6100418
Abstract
Highly pathogenic avian H5N1 influenza viruses that are currently circulating in southeast Asia may acquire the potential to cause the next influenza pandemic. A number of alternate approaches are be...Keywords
This publication has 59 references indexed in Scilit:
- The threat of avian influenza A (H5N1). Part IV: development of vaccinesMedical Microbiology and Immunology, 2007
- Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 InfluenzaPLoS Medicine, 2007
- Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protectionVirology, 2007
- Innate Immune Response to Adenoviral Vectors Is Mediated by both Toll-Like Receptor-Dependent and -Independent PathwaysJournal of Virology, 2007
- H5N1 Viruses and VaccinesPLoS Pathogens, 2007
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorThe Journal of Infectious Diseases, 2006
- Emerging Respiratory Viruses: Challenges and Vaccine StrategiesClinical Microbiology Reviews, 2006
- Avian influenza vaccines: what's all the flap?The Lancet, 2006
- Evolution of H5N1 Avian Influenza Viruses in AsiaEmerging Infectious Diseases, 2005
- Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccineVirus Research, 2004